Bioceres Crop Solutions (BIOX) AI Stock Analysis

• Market Cap: $85.99M
• Dividend Yield: N/A
• Average Volume (3M): 1.08M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.72
• Revenue Growth: -27.90%
• EPS Growth: -4194.67%
• Country: US
• Employees: 400
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): -0.12
• Shares Outstanding: 63,228,237
• 10 Day Avg. Volume: 1,709,433
• 30 Day Avg. Volume: 1,077,044
• PEG Ratio: <0.01
• Price to Book (P/B): 1.07
• Price to Sales (P/S): 0.85
• P/FCF Ratio: 8.00
• Enterprise Value/Market Cap: 0.00
• Enterprise Value/Revenue: 0.00
• Enterprise Value/Gross Profit: 0.00
• Enterprise Value/Ebitda: 0.00
• 1Y Price Target: $2.25
• Price Target Upside: 70.45% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 2
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 49 Neutral
• Price Target: $1.50 ▲(13.64% Upside)

Bioceres Crop Solutions faces significant challenges, primarily due to declining revenues and profitability issues, as reflected in its financial performance and valuation scores. Technical analysis indicates bearish momentum, further weighing on the stock. While the earnings call highlighted some improvements in gross margin and cost efficiency, these are overshadowed by revenue declines and debt concerns. The company's focus on profitability and liquidity is crucial for future resilience, but current market conditions and financial metrics suggest caution.

Positive Factors

Gross Margin Expansion

The significant improvement in gross margin indicates enhanced operational efficiency and a more profitable product mix, which can support long-term profitability.

Cost Efficiency

Effective cost management through SG&A reductions enhances profitability and financial flexibility, aiding in sustaining operations during challenging periods.

Leadership Strengthening

Strengthening leadership with experienced individuals can improve strategic governance and financial oversight, supporting long-term business resilience.

Negative Factors

Revenue Decline

A significant decline in revenue reflects challenges in market demand and strategic transitions, which could hinder growth prospects if not addressed.

Debt Levels

High debt levels can strain financial resources and limit the company's ability to invest in growth opportunities, posing a risk to long-term stability.

Legal Dispute

Ongoing legal disputes regarding debt obligations can create financial uncertainty and divert management focus from strategic initiatives.

Bioceres Crop Solutions Business Overview & Revenue Model

Company Description

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.

How the Company Makes Money

Bioceres Crop Solutions generates revenue through several key streams. First, it sells proprietary seed traits that are designed to improve crop performance and resistance to various stresses. Second, the company offers crop protection products, which include biological and chemical solutions aimed at safeguarding crops from pests and diseases. Additionally, Bioceres has developed partnerships with agricultural distributors and other industry players, which help expand its market reach and enhance its product offerings. The company also benefits from licensing agreements and collaborations in research and development, allowing it to capitalize on its innovations while sharing the financial risks associated with new product development. Overall, Bioceres' revenue model is built on a combination of direct sales, partnerships, and strategic collaborations that leverage its expertise in agricultural biotechnology.

Bioceres Crop Solutions Financial Statement Overview

Summary

Bioceres Crop Solutions faces challenges with declining revenue and profitability, as evidenced by negative net profit margins and revenue growth rates. The balance sheet reveals a high debt-to-equity ratio, which could be a risk factor. On the positive side, the company has shown improvement in free cash flow, which is crucial for sustaining operations and growth. Overall, while there are areas of concern, particularly in profitability and leverage, the company is making strides in cash flow management.

Income Statement

Bioceres Crop Solutions has experienced declining revenue growth, with a negative growth rate in the TTM period. The company also shows negative net profit margins, indicating ongoing profitability challenges. However, the gross profit margin remains relatively stable, suggesting some operational efficiency. The negative EBIT margin highlights difficulties in covering operating expenses.

Balance Sheet

The company's debt-to-equity ratio is over 1, indicating a higher reliance on debt financing, which could pose risks if not managed properly. The return on equity is negative, reflecting challenges in generating returns for shareholders. However, the equity ratio indicates a reasonable proportion of equity financing relative to total assets.

Cash Flow

Bioceres shows positive free cash flow growth in the TTM period, which is a positive sign for liquidity. The operating cash flow to net income ratio is low, suggesting that cash generation from operations is not strong relative to net income. However, the free cash flow to net income ratio is relatively high, indicating efficient cash conversion from earnings.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	318.23M	333.30M	464.83M	419.45M	328.46M	206.70M
Gross Profit	124.48M	130.20M	181.59M	180.25M	126.44M	90.88M
EBITDA	17.14M	13.59M	55.45M	72.38M	47.91M	43.70M
Net Income	-52.83M	-51.80M	3.24M	18.78M	-7.20M	-6.87M
Balance Sheet
Total Assets	734.88M	763.65M	852.55M	818.06M	518.22M	394.59M
Cash, Cash Equivalents and Short-Term Investments	16.61M	34.74M	56.17M	60.05M	38.61M	46.78M
Total Debt	267.74M	276.61M	270.95M	257.41M	169.79M	174.58M
Total Liabilities	455.83M	468.43M	501.17M	487.56M	359.92M	304.30M
Stockholders Equity	249.38M	262.81M	315.30M	298.85M	127.61M	67.74M
Cash Flow
Free Cash Flow	36.54M	35.30M	18.93M	-19.97M	-26.51M	-20.13M
Operating Cash Flow	45.23M	49.91M	41.72M	2.59M	-17.52M	-6.21M
Investing Cash Flow	-7.67M	-6.13M	-28.73M	-25.73M	2.90M	-8.31M
Financing Cash Flow	-56.76M	-50.71M	-10.06M	32.95M	14.82M	7.36M

Bioceres Crop Solutions Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.32
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BIOX, the sentiment is Negative. The current price of 1.32 is below the 20-day moving average (MA) of 1.53, below the 50-day MA of 1.67, and below the 200-day MA of 3.17, indicating a bearish trend. The MACD of -0.08 indicates Positive momentum. The RSI at 37.46 is Neutral, neither overbought nor oversold. The STOCH value of 8.82 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BIOX.

Bioceres Crop Solutions Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
RKDA	50 Neutral	$4.17M	-0.70	-64.08%	―	-1.80%	15.74%
BIOX	49 Neutral	$85.99M	-1.43	-20.52%	―	-27.90%	-4194.67%
SEED	46 Neutral	$14.82M	-17.77	―	―	-21.82%	-104.92%
AVD	45 Neutral	$113.30M	-1.03	-40.84%	―	-4.29%	-276.74%
LVRO	44 Neutral	$71.36M	-0.38	―	―	―	―
BHST	41 Neutral	$126.98M	-7.78	-200.22%	―	45.88%	43.12%

Bioceres Crop Solutions Corporate Events

Bioceres Crop Solutions Releases Q3 2025 Financial Update

Bioceres Crop Solutions Corp. released its unaudited interim condensed consolidated financial statements for the periods ending September 30, 2025, and June 30, 2025. The financial report indicates a decrease in total assets from $763.6 million to $734.9 million, and a reduction in total liabilities from $468.4 million to $446.5 million. This financial update provides stakeholders with insights into the company’s current financial health and operational adjustments over the recent quarter.

Bioceres Crop Solutions Reports Q1 2026 Financial Results Amid Strategic Transition

Bioceres Crop Solutions reported its fiscal first quarter 2026 financial results, with total revenues of $77.5 million, marking a 17% decline year-over-year. Despite the revenue drop due to strategic reductions in low-margin sales and seed model transition, the company achieved a gross margin expansion from 40% to 47%, reflecting a more profitable product mix. The net loss widened to $7.5 million, but operating profit and adjusted EBITDA saw significant improvements, driven by cost discipline and restructuring efforts. The company remains focused on enhancing capital structure and financial flexibility amidst challenging market conditions in Argentina.

Bioceres Crop Solutions Faces Legal Action Over Alleged Defaults

On November 10, 2025, Bioceres Crop Solutions received an Acceleration Notice from its noteholders, alleging defaults under its Convertible and Non-Convertible Note Purchase Agreements. Subsequently, on November 11, 2025, these noteholders initiated legal proceedings against Bioceres in the New York Supreme Court, seeking full payment of outstanding amounts. Bioceres disputes the allegations and intends to defend its position vigorously, reserving all rights against the noteholders.

Bioceres Crop Solutions Strengthens Leadership with New Appointments

On November 5, 2025, Bioceres Crop Solutions Corp. announced the appointment of Mr. Simon Vumbaca to its Board of Directors and Mr. Alejandro Villafane as the Principal Accounting Officer. Mr. Vumbaca brings expertise in high-stakes strategies and governance, while Mr. Villafane will oversee the company’s accounting functions. These appointments are expected to strengthen Bioceres’ strategic and financial leadership, potentially enhancing its market position and operational resilience.

Bioceres Crop Solutions Faces Board Resignation Amid Financial Dispute

On September 30, 2025, Noah Kolatch resigned from the board of directors of Bioceres Crop Solutions Corp. following a reservation of rights letter from Jasper Lake Ventures One LLC. The letter, dated September 25, 2025, alleged several defaults under a Note Purchase Agreement. In response, Bioceres disputed these claims, emphasizing the importance of dialogue with Jasper Lake to address any concerns. The company remains committed to improving its commercial and financial performance while maintaining its focus on delivering innovative agricultural solutions.